Cemil Bayram
Erzurum, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Neuroprotective effects of chitosan nanoparticle-loaded orientin in a 6-OHDA-induced Parkinson's disease experimental model in rats.
Journal: Neuropharmacology
Published: July 15, 2026
Differential Modulation of Central Sensitization Pathways by Common Antipsychotics in a Paclitaxel-Induced Neuropathic Pain Model.
Journal: European journal of pharmacology
Published: May 14, 2026
Dapagliflozin ameliorates motor deficits in a Parkinson's disease model induced by 6-OHDA: An integrative in vivo and in silico approach from α-synuclein/A2AAR/TH/TNF-α to APAF-1/caspase-3 modulation.
Journal: Inflammopharmacology
Published: March 03, 2026
Zinc Oxide Nanoparticles Mitigate Nonylphenol-Induced Testicular Toxicity by Modulating Blood-Testis Barrier Proteins and JAK2/STAT3 Signaling.
Journal: Journal of applied toxicology : JAT
Published: January 30, 2026
Modulation of Oxidative Stress and Apoptosis by Antrodia cinnamomea-Loaded Citrate-Stabilized Silver Nanoparticles in Experimental Parkinsonism.
Journal: Molecular neurobiology
Published: January 05, 2026
Pycnogenol attenuates thioacetamide-induced neurobehavioral impairment and hepatotoxicity via multi-target molecular modulation.
Journal: BMC pharmacology & toxicology
Published: November 27, 2025
Fracture healing potential of tetracalcium phosphate: An experimental study in a rat femur standardized diaphyseal osteotomy with open approach.
Journal: Joint diseases and related surgery
Published: July 13, 2025
Colemanite and biological disruptions: Behavioral, neurological, and physiological findings.
Journal: Regulatory toxicology and pharmacology : RTP
Published: February 05, 2025
Boric acid impedes glioblastoma growth in a rat model: insights from multi-approach analysis.
Journal: Medical oncology (Northwood, London, England)
Published: November 01, 2024
Corrigendum to "Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning" [eBioMedicine, 2022;83:104214].
Journal: EBioMedicine
Published: June 29, 2024
Last Updated: 09/26/2026